LGDN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Ligand Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 272 EUR 4.62% Market Closed

Market Cap: €4.9B

L	Ligand Pharmaceuticals Inc F:LGDN	US
I	Intuitive Surgical Inc XMUN:IUI1	US
A	Aran Research and Development 1982 Ltd TASE:ARAN	IL

Profitability Summary

Ligand Pharmaceuticals Inc's profitability score is 65/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

95%

Strong 3Y Average Gross Margin

92%

Gross Margin is Increasing

77% > 95%

Exceptional Operating Margin

32%

Low 3Y Average Operating Margin

Operating Margin is Increasing

19% > 32%

Exceptional Net Margin

68%

Sustainable 3Y Average Net Margin

23%

Net Margin is Increasing

13% > 68%

Exceptional Free Cash Flow Margin

46%

Strong 3Y Average Free Cash Flow Margin

23%

Declining Free Cash Flow Margin

View All

Hide

Collapse

65 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.